Porphyria cutanea tarda: an intriguing genetic disease and marker

Porphyrias are a group of intriguing genetic diseases of the heme pathway, of which porphyria cutanea tarda (PCT) is the most common. Resulting from a defect in enzymes in the porphyria pathway, PCT has been linked to several conditions. Recent studies have demonstrated a change in thinking regardin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of dermatology 2017-06, Vol.56 (6), p.e106-e117
Hauptverfasser: Handler, Nancy S., Handler, Marc Z., Stephany, Matthew P., Handler, Glenn A., Schwartz, Robert A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e117
container_issue 6
container_start_page e106
container_title International journal of dermatology
container_volume 56
creator Handler, Nancy S.
Handler, Marc Z.
Stephany, Matthew P.
Handler, Glenn A.
Schwartz, Robert A.
description Porphyrias are a group of intriguing genetic diseases of the heme pathway, of which porphyria cutanea tarda (PCT) is the most common. Resulting from a defect in enzymes in the porphyria pathway, PCT has been linked to several conditions. Recent studies have demonstrated a change in thinking regarding the human immunodeficiency virus (HIV) and development of PCT. The exacerbation of PCT with contraction of HIV is now believed to result from coinfection from the hepatitis C virus (HCV). Blistering of sun‐exposed skin, a classic presenting sign of PCT, is not exclusive to the condition. Cutaneous findings must also trigger physicians to consider additional types of porphyrias, such as variegate porphyria. The diagnosis of pseudoporphyria, which does not result from enzymatic absence, must be considered in patients with photosensitivity and cutaneous bullae. Recent health food trends, such as chlorophyll, have been linked to pseudoporphyria. PCT is a serious condition in which accurate diagnosis is necessary for appropriate management.
doi_str_mv 10.1111/ijd.13580
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1879665978</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1879665978</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3530-8b649aba98da451a39a7c12e280cc779e4e2e1ea8e0be5486016469f5e1237863</originalsourceid><addsrcrecordid>eNp1kMtOwzAQRS0EoqWw4AdQJDawSOt3bHZVeRVVggWsLSeZFpc2KXYi1L_HkMICidnMjObo6s5F6JTgIYk1cstySJhQeA_1CZMi5ZLRfdTHmJBUY6F76CiEZVwZJfwQ9aiKg2Kqj8ZPtd-8br2zSdE2tgKbNNaX9iqxVeKqxrtF66pFsoAKGlckpQtgA8RrmaytfwN_jA7mdhXgZNcH6OX25nlyn84e76aT8SwtmGA4Vbnk2uZWq9JyQSzTNisIBapwUWSZBg4UCFgFOAfBlcREcqnnAghlmZJsgC463Y2v31sIjVm7UMBqFU3XbTBEZVpKoTMV0fM_6LJufRXdGaIpFkpzyiN12VGFr0PwMDcb7-JPW0Ow-crVxFzNd66RPdsptvkayl_yJ8gIjDrgw61g-7-SmT5cd5Kf7r9_eg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1920589424</pqid></control><display><type>article</type><title>Porphyria cutanea tarda: an intriguing genetic disease and marker</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Handler, Nancy S. ; Handler, Marc Z. ; Stephany, Matthew P. ; Handler, Glenn A. ; Schwartz, Robert A.</creator><creatorcontrib>Handler, Nancy S. ; Handler, Marc Z. ; Stephany, Matthew P. ; Handler, Glenn A. ; Schwartz, Robert A.</creatorcontrib><description>Porphyrias are a group of intriguing genetic diseases of the heme pathway, of which porphyria cutanea tarda (PCT) is the most common. Resulting from a defect in enzymes in the porphyria pathway, PCT has been linked to several conditions. Recent studies have demonstrated a change in thinking regarding the human immunodeficiency virus (HIV) and development of PCT. The exacerbation of PCT with contraction of HIV is now believed to result from coinfection from the hepatitis C virus (HCV). Blistering of sun‐exposed skin, a classic presenting sign of PCT, is not exclusive to the condition. Cutaneous findings must also trigger physicians to consider additional types of porphyrias, such as variegate porphyria. The diagnosis of pseudoporphyria, which does not result from enzymatic absence, must be considered in patients with photosensitivity and cutaneous bullae. Recent health food trends, such as chlorophyll, have been linked to pseudoporphyria. PCT is a serious condition in which accurate diagnosis is necessary for appropriate management.</description><identifier>ISSN: 0011-9059</identifier><identifier>EISSN: 1365-4632</identifier><identifier>DOI: 10.1111/ijd.13580</identifier><identifier>PMID: 28321838</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Blistering ; Chlorophyll ; Contraction ; Diagnosis ; Diagnosis, Differential ; Disease Progression ; Enzymes ; Food ; Heme ; Heme - biosynthesis ; Hepatitis ; Hepatitis C ; HIV ; Human immunodeficiency virus ; Humans ; Medical personnel ; Photosensitivity ; Physicians ; Porphyria ; Porphyria cutanea tarda ; Porphyria Cutanea Tarda - diagnosis ; Porphyria Cutanea Tarda - enzymology ; Porphyria Cutanea Tarda - genetics ; Porphyria Cutanea Tarda - therapy ; Porphyrias, Hepatic - diagnosis ; Risk Factors ; Skin ; Viruses</subject><ispartof>International journal of dermatology, 2017-06, Vol.56 (6), p.e106-e117</ispartof><rights>2017 The International Society of Dermatology</rights><rights>2017 The International Society of Dermatology.</rights><rights>International Journal of Dermatology © 2017 International Society of Dermatology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3530-8b649aba98da451a39a7c12e280cc779e4e2e1ea8e0be5486016469f5e1237863</citedby><cites>FETCH-LOGICAL-c3530-8b649aba98da451a39a7c12e280cc779e4e2e1ea8e0be5486016469f5e1237863</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fijd.13580$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fijd.13580$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28321838$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Handler, Nancy S.</creatorcontrib><creatorcontrib>Handler, Marc Z.</creatorcontrib><creatorcontrib>Stephany, Matthew P.</creatorcontrib><creatorcontrib>Handler, Glenn A.</creatorcontrib><creatorcontrib>Schwartz, Robert A.</creatorcontrib><title>Porphyria cutanea tarda: an intriguing genetic disease and marker</title><title>International journal of dermatology</title><addtitle>Int J Dermatol</addtitle><description>Porphyrias are a group of intriguing genetic diseases of the heme pathway, of which porphyria cutanea tarda (PCT) is the most common. Resulting from a defect in enzymes in the porphyria pathway, PCT has been linked to several conditions. Recent studies have demonstrated a change in thinking regarding the human immunodeficiency virus (HIV) and development of PCT. The exacerbation of PCT with contraction of HIV is now believed to result from coinfection from the hepatitis C virus (HCV). Blistering of sun‐exposed skin, a classic presenting sign of PCT, is not exclusive to the condition. Cutaneous findings must also trigger physicians to consider additional types of porphyrias, such as variegate porphyria. The diagnosis of pseudoporphyria, which does not result from enzymatic absence, must be considered in patients with photosensitivity and cutaneous bullae. Recent health food trends, such as chlorophyll, have been linked to pseudoporphyria. PCT is a serious condition in which accurate diagnosis is necessary for appropriate management.</description><subject>Blistering</subject><subject>Chlorophyll</subject><subject>Contraction</subject><subject>Diagnosis</subject><subject>Diagnosis, Differential</subject><subject>Disease Progression</subject><subject>Enzymes</subject><subject>Food</subject><subject>Heme</subject><subject>Heme - biosynthesis</subject><subject>Hepatitis</subject><subject>Hepatitis C</subject><subject>HIV</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Medical personnel</subject><subject>Photosensitivity</subject><subject>Physicians</subject><subject>Porphyria</subject><subject>Porphyria cutanea tarda</subject><subject>Porphyria Cutanea Tarda - diagnosis</subject><subject>Porphyria Cutanea Tarda - enzymology</subject><subject>Porphyria Cutanea Tarda - genetics</subject><subject>Porphyria Cutanea Tarda - therapy</subject><subject>Porphyrias, Hepatic - diagnosis</subject><subject>Risk Factors</subject><subject>Skin</subject><subject>Viruses</subject><issn>0011-9059</issn><issn>1365-4632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtOwzAQRS0EoqWw4AdQJDawSOt3bHZVeRVVggWsLSeZFpc2KXYi1L_HkMICidnMjObo6s5F6JTgIYk1cstySJhQeA_1CZMi5ZLRfdTHmJBUY6F76CiEZVwZJfwQ9aiKg2Kqj8ZPtd-8br2zSdE2tgKbNNaX9iqxVeKqxrtF66pFsoAKGlckpQtgA8RrmaytfwN_jA7mdhXgZNcH6OX25nlyn84e76aT8SwtmGA4Vbnk2uZWq9JyQSzTNisIBapwUWSZBg4UCFgFOAfBlcREcqnnAghlmZJsgC463Y2v31sIjVm7UMBqFU3XbTBEZVpKoTMV0fM_6LJufRXdGaIpFkpzyiN12VGFr0PwMDcb7-JPW0Ow-crVxFzNd66RPdsptvkayl_yJ8gIjDrgw61g-7-SmT5cd5Kf7r9_eg</recordid><startdate>201706</startdate><enddate>201706</enddate><creator>Handler, Nancy S.</creator><creator>Handler, Marc Z.</creator><creator>Stephany, Matthew P.</creator><creator>Handler, Glenn A.</creator><creator>Schwartz, Robert A.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>201706</creationdate><title>Porphyria cutanea tarda: an intriguing genetic disease and marker</title><author>Handler, Nancy S. ; Handler, Marc Z. ; Stephany, Matthew P. ; Handler, Glenn A. ; Schwartz, Robert A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3530-8b649aba98da451a39a7c12e280cc779e4e2e1ea8e0be5486016469f5e1237863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Blistering</topic><topic>Chlorophyll</topic><topic>Contraction</topic><topic>Diagnosis</topic><topic>Diagnosis, Differential</topic><topic>Disease Progression</topic><topic>Enzymes</topic><topic>Food</topic><topic>Heme</topic><topic>Heme - biosynthesis</topic><topic>Hepatitis</topic><topic>Hepatitis C</topic><topic>HIV</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Medical personnel</topic><topic>Photosensitivity</topic><topic>Physicians</topic><topic>Porphyria</topic><topic>Porphyria cutanea tarda</topic><topic>Porphyria Cutanea Tarda - diagnosis</topic><topic>Porphyria Cutanea Tarda - enzymology</topic><topic>Porphyria Cutanea Tarda - genetics</topic><topic>Porphyria Cutanea Tarda - therapy</topic><topic>Porphyrias, Hepatic - diagnosis</topic><topic>Risk Factors</topic><topic>Skin</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Handler, Nancy S.</creatorcontrib><creatorcontrib>Handler, Marc Z.</creatorcontrib><creatorcontrib>Stephany, Matthew P.</creatorcontrib><creatorcontrib>Handler, Glenn A.</creatorcontrib><creatorcontrib>Schwartz, Robert A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Handler, Nancy S.</au><au>Handler, Marc Z.</au><au>Stephany, Matthew P.</au><au>Handler, Glenn A.</au><au>Schwartz, Robert A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Porphyria cutanea tarda: an intriguing genetic disease and marker</atitle><jtitle>International journal of dermatology</jtitle><addtitle>Int J Dermatol</addtitle><date>2017-06</date><risdate>2017</risdate><volume>56</volume><issue>6</issue><spage>e106</spage><epage>e117</epage><pages>e106-e117</pages><issn>0011-9059</issn><eissn>1365-4632</eissn><abstract>Porphyrias are a group of intriguing genetic diseases of the heme pathway, of which porphyria cutanea tarda (PCT) is the most common. Resulting from a defect in enzymes in the porphyria pathway, PCT has been linked to several conditions. Recent studies have demonstrated a change in thinking regarding the human immunodeficiency virus (HIV) and development of PCT. The exacerbation of PCT with contraction of HIV is now believed to result from coinfection from the hepatitis C virus (HCV). Blistering of sun‐exposed skin, a classic presenting sign of PCT, is not exclusive to the condition. Cutaneous findings must also trigger physicians to consider additional types of porphyrias, such as variegate porphyria. The diagnosis of pseudoporphyria, which does not result from enzymatic absence, must be considered in patients with photosensitivity and cutaneous bullae. Recent health food trends, such as chlorophyll, have been linked to pseudoporphyria. PCT is a serious condition in which accurate diagnosis is necessary for appropriate management.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>28321838</pmid><doi>10.1111/ijd.13580</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0011-9059
ispartof International journal of dermatology, 2017-06, Vol.56 (6), p.e106-e117
issn 0011-9059
1365-4632
language eng
recordid cdi_proquest_miscellaneous_1879665978
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Blistering
Chlorophyll
Contraction
Diagnosis
Diagnosis, Differential
Disease Progression
Enzymes
Food
Heme
Heme - biosynthesis
Hepatitis
Hepatitis C
HIV
Human immunodeficiency virus
Humans
Medical personnel
Photosensitivity
Physicians
Porphyria
Porphyria cutanea tarda
Porphyria Cutanea Tarda - diagnosis
Porphyria Cutanea Tarda - enzymology
Porphyria Cutanea Tarda - genetics
Porphyria Cutanea Tarda - therapy
Porphyrias, Hepatic - diagnosis
Risk Factors
Skin
Viruses
title Porphyria cutanea tarda: an intriguing genetic disease and marker
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T03%3A43%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Porphyria%20cutanea%20tarda:%20an%20intriguing%20genetic%20disease%20and%20marker&rft.jtitle=International%20journal%20of%20dermatology&rft.au=Handler,%20Nancy%20S.&rft.date=2017-06&rft.volume=56&rft.issue=6&rft.spage=e106&rft.epage=e117&rft.pages=e106-e117&rft.issn=0011-9059&rft.eissn=1365-4632&rft_id=info:doi/10.1111/ijd.13580&rft_dat=%3Cproquest_cross%3E1879665978%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1920589424&rft_id=info:pmid/28321838&rfr_iscdi=true